Editas Medicine, Inc. (EDIT)

Editas Medicine Market Cap

Editas Medicine has a market cap or net worth of $439.87 million as of April 26, 2024. Its market cap has decreased by -20.87% in one year.

• Market Cap: 439.87M
• Enterprise Value: 142.69M
• 1-Year Change: -20.87%
• Ranking: #3063
• Category: Small-Cap
• Stock Price: $5.36

Market Cap Chart

Since February 3, 2016, Editas Medicine's market cap has decreased from $649.70M to $439.87M, a decrease of -32.30%. That is a compound annual growth rate of -4.63%.

Market Cap History

Date	Market Cap	% Change
Apr 24, 2024	437.70M	-2.01%
Apr 23, 2024	446.70M	-2.51%
Apr 22, 2024	458.20M	2.00%
Apr 19, 2024	449.20M	-1.08%
Apr 18, 2024	454.10M	-1.07%
Apr 17, 2024	459.00M	-4.10%
Apr 16, 2024	478.60M	-3.78%
Apr 15, 2024	497.40M	-2.11%
Apr 12, 2024	508.10M	-5.61%
Apr 11, 2024	538.30M	-0.76%
Apr 10, 2024	542.40M	-5.42%
Apr 9, 2024	573.50M	4.31%
Apr 8, 2024	549.80M	-
Apr 5, 2024	549.80M	-1.33%
Apr 4, 2024	557.20M	-0.71%
Apr 3, 2024	561.20M	-0.16%
Apr 2, 2024	562.10M	-5.62%
Apr 1, 2024	595.60M	-1.89%
Mar 28, 2024	607.10M	-0.26%
Mar 27, 2024	608.70M	3.05%
Mar 26, 2024	590.70M	-1.89%
Mar 25, 2024	602.10M	-1.47%
Mar 22, 2024	611.10M	-4.61%
Mar 21, 2024	640.60M	-1.14%
Mar 20, 2024	648.00M	2.19%

View and export this data all the way back to 2016. Sign Up Today.

Related Stocks

Company	Market Cap
Nevro	465.53M
Fulcrum Therapeutics	460.80M
IGM Biosciences	453.90M
Shattuck Labs	450.54M
Third Harmonic Bio	449.89M
Acelyrin	447.76M
Theravance Biopharma	444.08M
LifeMD	439.59M